| Literature DB >> 30713112 |
Chiara Briani1, Alessandro Salvalaggio2, Marta Ruiz2, Mario Cacciavillani3, Francesca Rinaldi2, Ilaria Callegari4, Roberto Gasparotti5, Diego Franciotta6.
Abstract
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with anti-neurofascin-155 antibodies is a subgroup of CIDP with tremor and poor response to intravenous immunoglobulins. A 23-year-old male presented with a 6-month history ataxic-stepping gait, stocking tactile hypoesthesia, areflexia, tremor at limbs and tongue. Neurophysiology and cerebrospinal fluid analysis supported the diagnosis of CIDP. Tongue EMG was negative. Serum was positive for neurofascin-155 IgG4. His symptoms improved with intravenous methylprednisolone and then immunoglobulins, but not the tremor. Neurofascin-155 antibodies binding to cerebellar neurons suggests its central origin. This is the first neurofascin-155 antibody-seropositive patient with also tongue tremor, who is candidate to rituximab.Entities:
Keywords: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); Neurofascin-155; Tremor, tongue
Mesh:
Substances:
Year: 2019 PMID: 30713112 DOI: 10.1016/j.jneuroim.2019.01.017
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478